(Q30376917)

21 June 2017

1 reference

title

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. (English)

1 reference

21 June 2017

1 reference

5

Donald F Smee

1 reference

21 June 2017

9

John D Morrey

1 reference

21 June 2017

Yousuke Furuta

1

1 reference

21 June 2017

Kazumi Takahashi

2

1 reference

21 June 2017

Kimiyasu Shiraki

3

1 reference

21 June 2017

Kenichi Sakamoto

4

1 reference

21 June 2017

Dale L Barnard

6

1 reference

21 June 2017

Brian B Gowen

7

1 reference

21 June 2017

Justin G Julander

8

1 reference

21 June 2017

6 March 2009

1 reference

21 June 2017

1 reference

21 June 2017

82

1 reference

21 June 2017

3

1 reference

21 June 2017

95-102

1 reference

Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents

21 June 2017

1 reference

12 December 2020

Mechanism of action of T-705 against influenza virus

1 reference

12 December 2020

Treatment of Bolivian hemorrhagic fever with intravenous ribavirin.

1 reference

12 December 2020

Highly pathogenic RNA viral infections: challenges for antiviral research.

1 reference

12 December 2020

Update on avian influenza A (H5N1) virus infection in humans

1 reference

12 December 2020

The anti-yellow fever virus activity of ribavirin is independent of error-prone replication

1 reference

12 December 2020

Synthesis and antiviral activity of some phosphates of the broad-spectrum antiviral nucleoside, 1-.beta.-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin)

1 reference

12 December 2020

Foot-and-mouth disease

1 reference

12 December 2020

Antiviral treatment of Argentine hemorrhagic fever

1 reference

12 December 2020

Vaccines: past, present and future

1 reference

12 December 2020

Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin

1 reference

12 December 2020

West Nile virus: Uganda, 1937, to New York City, 1999.

1 reference

12 December 2020

Are we ready for pandemic influenza?

1 reference

12 December 2020

Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106

1 reference

12 December 2020

The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran

1 reference

12 December 2020

In vitro and in vivo activities of T-705 and oseltamivir against influenza virus

1 reference

12 December 2020

Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses

1 reference

12 December 2020

Descriptive epidemiology of the 2001 foot-and-mouth disease epidemic in Great Britain: the first five months

1 reference

12 December 2020

Activity of T-1106 in a Hamster Model of Yellow Fever Virus Infection

1 reference

12 December 2020

Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon

1 reference

12 December 2020

Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice

1 reference

12 December 2020

Recombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters

1 reference

12 December 2020

Zoonotic viral diseases and the frontier of early diagnosis, control and prevention.

1 reference

12 December 2020

Yellow fever: the recurring plague

1 reference

12 December 2020

Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy

1 reference

12 December 2020

In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections

1 reference

12 December 2020

Treatment of Crimean-Congo hemorrhagic fever

1 reference

12 December 2020

Natural adaption to pigs of a Taiwanese isolate of foot-and-mouth disease virus

1 reference

12 December 2020

Serious morbidity and mortality associated with influenza epidemics

1 reference

12 December 2020

Hemorrhagic fever viruses as biological weapons: medical and public health management

1 reference

12 December 2020

In vitro and in vivo activities of anti-influenza virus compound T-705.

1 reference

12 December 2020

Avian influenza viruses and their implication for human health.

1 reference

12 December 2020

Error-prone replication of West Nile virus caused by ribavirin

1 reference

12 December 2020

Emerging viral diseases and infectious disease risks

1 reference

12 December 2020

Treatment of yellow fever

1 reference

12 December 2020

Natural and vaccine-induced immunity to foot and mouth disease: the prospects for improved vaccines.

1 reference

12 December 2020

Lassa fever. Effective therapy with ribavirin

1 reference

12 December 2020

10.1016/J.ANTIVIRAL.2009.02.198

Identifiers

DOI

1 reference

21 June 2017

0 references

1 reference